Product Code: RP-ID-10078997 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10078997
Market Overview:
Forecast 2018 – 2025 | IVD Industry By Top Key Players (Abbott Laboratories, Beckman Coulter Inc., Biomérieux SA) By Type(Instruments, Software and Services, Reagents & Kits) and By Technique(Immunodiagnostics, Blood testing, Molecular diagnostics, Tissue diagnostics) - Global Opportunity and Current Growth Analysis
Global IVD Industry was valued at USD 62 Billion in the year 2017. Global IVD Industry is further estimated to grow at a CAGR of 6.61% from 2018 to 2025 reach USD 91.04 Billion. North America region holds the highest Industry share in 2017 while APAC region is considered as the fastest growing Industry in the forecasted period. At a country level, the U.S is the biggest Industry in 2017 and it is projected to grow at a gradual pace in the coming years.
The major players in IVD Industry are Abbott Laboratories, Beckman Coulter Inc., Biomérieux SA, Grifols SA, F.Hoffmann-La Roche AG, Becton Dickinson and Company, Qiagen Netherlands, Danaher Corporation (Beckman Coulter) Lab 21, Siemens AG, Johnson & Johnson and other 10 companies information is provided in research report.
Global IVD Industry with Roche Diagnostics holding the highest Industry share. Better global reach, both at production and at an operational level is the main reason for holding this highest Industry share. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key Industry drivers. Organic growth strategies adopted by most of the top manufacturers in recent years is also provided comprehensive Industry opportunities for the various stakeholder.
SWOT Analysis of IVD Industry
Strength
Growing awareness of self-care medicines
Growing infectious disease Industry and adoption of point-of-care testing
Weakness
Lack of regulatory standards
Rising cost of better healthcare facilities
Opportunity
Increasing significance of diagnostics in improving healthcare quality
Growing R&D investments.
Threats
Intense competition and declining healthcare reimbursement
The report is segmented as, by type, by technology, by end users, and by region. The reagents and kits segment by type is likely to hold the largest Industry share during the forecast period. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income) with a wide range of available reagents and kits. On the other hand, hospitals by users are expected to grow at the highest CAGR during the year 2018-2025 as increasing number of diagnostics tests carried out in hospitals.
Global IVD Industry Overview By Type
Instruments
Software and Services
Reagents & Kits
Global IVD Industry Overview By Technique
Immunodiagnostics
Blood testing
Molecular diagnostics
Tissue diagnostics
Clinical chemistry
Other IVD techniques
Global IVD Industry Overview By Users
Hospitals
Point of Care Testing
Academic and Medical Schools
Others
Global IVD Industry Overview By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Related Reports
Proof of Quality & Reliability
